Zemplar

Paricalcitol (Zemplar) is a vitamin D analog prescribed to manage secondary hyperparathyroidism in adults undergoing haemodialysis. This prescription-only medication helps regulate calcium and phosphorus levels. Suitable for intravenous use during dialysis sessions. Always follow healthcare provider guidance when using this treatment.

Paricalcitol is used to treat secondary hyperparathyroidism in adults receiving haemodialysis. It works by reducing elevated parathyroid hormone levels, which can impact bone health. This medication is specifically formulated for patients with chronic kidney disease requiring dialysis. It is not intended for conditions unrelated to secondary hyperparathyroidism.

Paricalcitol may help restore balance to calcium and phosphorus levels in the body. Patients often notice improved bone health markers over time with consistent use. Some individuals report reduced muscle weakness or bone pain as secondary benefits. Effects vary based on individual health conditions and treatment adherence.

Store paricalcitol at controlled room temperature, away from moisture and direct light. Keep this medication out of reach of children and pets. Always use as directed by a healthcare professional. Report any unusual symptoms to your doctor promptly. Do not adjust dosage without medical supervision.

Paricalcitol may interact with other medications affecting calcium or vitamin D metabolism. Caution is advised when using phosphate binders, calcium supplements, or CYP3A inhibitors. Grapefruit products may alter how the body processes paricalcitol. Always inform your healthcare provider about all medications and supplements you are taking.